SC
PRAH

Samlyn Capital’s PRA Health Sciences, Inc. PRAH Stock Holding History

Samlyn Capital’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-785,246
Closed -$43.3M – 169
2016
Q4 		$43.3M Buy
785,246
+255,746
+48% +$14M 0.98% 44
2016
Q3 		$29.9M Buy
+529,500
New +$26M 0.71% 60

Other funds holding PRAH

KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Samlyn Capital's PRAH Position: Q1 2017 in Review

Samlyn Capital sold out of PRA Health Sciences, Inc. (PRAH) in Q1 2017, closing a stake of 785,246 shares — an estimated $43.3M sold.

Samlyn Capital first reported a position in PRAH in Q3 2016 and held it in 2 quarters. The position peaked at $43.3M in Q4 2016. 229 funds tracked by Wall St. Rank hold PRAH as of Q1 2017.

  • Samlyn Capital reported no remaining PRA Health Sciences, Inc. position as of Q1 2017 after selling out during the quarter.
  • Samlyn Capital sold 785,246 PRA Health Sciences, Inc. shares in Q1 2017, an estimated $43.3M.
  • Samlyn Capital first reported a position in PRA Health Sciences, Inc. in Q3 2016 and held it in 2 quarters.
  • Samlyn Capital's PRA Health Sciences, Inc. position peaked at $43.3M in Q4 2016.
  • 229 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q1 2017.

Based on Samlyn Capital's 13F filing for Q1 2017, filed 15 May 2017.